QOL-16 HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN A PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (HYPO-IMRT) WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV) FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Mohler, Alexander, Ney, Douglas, Gaspar, Laurie, Damek, Denise, Kavanagh, Brian, Reddy, Krishna, Chen, Changhu
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Abstracts from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639173/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov230.16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados